bibliographic entry 5049664 [be/5049664]
https://w3id.org/oc/corpus/be/5049664

is a
content
  • Sheppard, M, Bronstein, MD, Freda, P, Serri, O, De Marinis, L, Naves, L, Rozhinskaya, L, Hermosillo Resendiz, K, Ruffin, M, Chen, Y, Colao, A. Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, phase III study, Pituitary, 2015, 18, 3, 385, 394, DOI: 10.1007/s11102-014-0585-6, PMID: 25103549
references